References
- Weinstein L. Antimicrobial agents. The pharmacological basis of therapeutics, L S Goodman, A Gilman. Macmillan, New York 1975; 1167–82
- Siegel J D, McCracken G H, Jr. Aminoglycoside ototoxicity in children. Aminoglycoside ototoxicity, S Lerner, G Matz, J Hawkins, Jr. Little, Brown and Co., Mass 1981; 341–53
- Engstrom H, Kohonen A. Cochlear damage from ototoxic antibiotics. Acta Otolaryngol (Stockh) 1965; 59: 171–8
- Dallos P, Wang C Y. Bioelectric correlates of kanamycin intoxication. Audiology 1974; 13: 277–89
- Hawkins J E, Jr. The ototoxicity of kanamycin. Ann Otol Rhinol Laryngol 1959; 68: 698–715
- Nakai Y, Zushi K, Chang C, Yagi H, Tokimoto T. An experimental study on the progressiveness of cochlear damage by aminoglycoside drug. Acta Otolaryngol (Stockh) 1981; 91: 199–206
- Reinberg A, Smolensky M H. Circadian changes of drug disposition in man. Clin Pharmacokinetics 1982; 7: 401–20
- Reinberg A, Levi F, Smolensky M H. Clinical chronopharmacokinetics. J Pharmacol (Paris) 1984; 15(Suppl 1)95–124
- Di Santo A, Chodos D, Halberg F. Chronobioavailability of three erythromycin test preparations assessed by each of four indices: time to peak, peak, nadir and area. Chronobiologia 1975; 2(Suppl 1)17
- Sharma S D, Deshpande V A, Samuel M R, Vakil B J. Chronobioavailability of ampicillin. Chronobiologia 1979; 6: 156
- Scheving L E, Cardoso S S, Pauly J E, Halberg F, Haus E. Variation in susceptibility of mice to the carcinostatic agent arabinosyl cytosine. Chronobiology, L E Sheving, F Halberg, J E Pauly. Igaky Shoin, Tokyo 1974; 213–7
- Scheving L E, Burns E R, Pauly J E, Halberg H. Circadian bioperiodic response of mice bearing a L1210 leukemia to combination therapy with adriamycin and cyclophosphamide. Cancer Res 1980; 40: 1511–5
- Snyder N K, Smolensky M H, Hsi B P. Circadian variation in the susceptibility of male balb/c mice to ifosfamide. Chronobiologia 1981; 8: 33–44
- Hrushesky W, Levi F, Kennedy B J. Cis-diaminedichloroplatinum (DPP) toxicity to the human kidney reduced by circadian timing. Proceeding of the American Society for Clinical Oncology. 1980. 21: C45
- Wassick K, Yonovitz A. Methyl mercury ototoxicity in mice determined by auditory brainstem evoked responses. Acta Otolaryngol (Stockh) 1985; 99: 35–45
- Buchwald J S, Huang C M. Far-field acoustic response origins in the cat. Science 1975; 189: 382–4
- Evans B, Yonovitz A, Fox D A. Ototoxic effects of triethyltin: Electrophysiological and histological correlates. Toxicologist 1983; 3: 169
- Schwent V, Williston J, Jewett D. The effects of ototoxicity on the auditory brainstem response and the scalp recorded cochlear microphonic in guines pig. Laryngoscope 1980; 90: 1350–9
- Davis H. Brainstem and other responses in electric response audiometry. Ann Otol Rhino Laryngol 1976; 85: 3–14
- Galamos R, Hecox R. Clinical applications of the human brain stem responses to auditory stimuli. Auditory evoked potentials in man. Psychopharmacology correlates of evoked potentials. Prog Clin Neurophys, J E Desmedt. Karger, Basel 1977; 2: 1–19
- Pariat P, Cambar J, Courtois P. Circadian variations in the acute toxicity of three aminoglycosides: gentamicin, dibekacin, and netilmicin in mice. Annual Review of Chronopharmacology (Proceedings of the First International Montreaux Conference of Biological Rhythms and Medications), A Reinberg, M Smolensky, G Labrecque. Pergamon, Oxford 1984; 381–4
- Weiner N D, Schacht J. Biochemical model of aminoglycoside-induced hearing loss. Aminoglycoside ototoxicity, S Lerner, G Matz, J E Hawkins, Jr. Little, Brown and Co., Boston 1981; 113–21
- Komune S, Snow J B, Jr. Ototoxicity of kanamycin sulfate and the barriers in the inner ear. Otolaryngol Head Neck Surg 1981; 89: 1013–18
- Belanger P M, Labrecque G, Dore F. Rate limiting steps in the temporal variations in the metabolism of selected drugs. Int J Chronobiol 1981; 7: 208